TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ANIK

Anika Therapeutics Inc

Healthcare · Drug Manufacturers - Specialty & Generic

21.00$ +0.9% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Anika Therapeutics Inc (ANIK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 113 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ANIK
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
106 93 103 113 106 115 130 148 156 121 120 113
21 21 24 27 31 29 61 65 63 38 44 49
85 72 79 86 74 86 69 83 94 83 76 64
8.1 9.0 11 19 18 17 23 27 28 22 26 26
15 15 18 22 34 35 60 53 85 99 56 49
23 24 29 40 53 52 97 80 113 82 81 75
61 48 51 46 22 34 -28 2.6 -19 0.8 -5.1 -11
0.1 0.1 0.3 0.5 1.5 7.9 0.8 0.2 0.7 2.3 2.3 1.7
62 48 51 46 23 36 -29 2.4 -19 3.2 -2.8 -9.3
23 17 18 14 4.5 8.9 -4.6 -1.7 -3.9 6.6 6.1 0.7
38 31 33 32 19 27 -24 4.1 -15 -83 -56 -11
66 52 54 50 28 40 -1.0 -4.2 -4.9 17 5.4 -3.6

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?